Team Medical Affairs News Contact

Team Medical Affairs News Contact

Back

Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology

March 28, 2019

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Medical Affairs News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2023 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED